Clinical Trials Directory

Trials / Completed

CompletedNCT02306824

Berlin Atrial Fibrillation Registry

Berlin Cohort Study on Oral Anticoagulation in Patients With Atrial Fibrillation and Acute Ischemic Stroke

Status
Completed
Phase
Study type
Observational
Enrollment
1,080 (actual)
Sponsor
Charite University, Berlin, Germany · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Investigator-initiated prospective multicentre hospital-based registry to uncover the proportion of self-reported anticoagulation in stroke patients with atrial fibrillation and assessing the proportion of stroke, intracranial bleeding and all-cause death in the short (at 3 months), mid-term (at 12 months) as well as long term (at 24 months) after ischemic stroke or transient ischemic attack in an unselected urban population in Germany. In addition, annual follow-up is planned yearly up to 5 years after enrollment.

Conditions

Timeline

Start date
2014-12-01
Primary completion
2017-11-01
Completion
2020-11-01
First posted
2014-12-03
Last updated
2020-11-13

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT02306824. Inclusion in this directory is not an endorsement.